Elbaz Avi, Mor Amit, Segal Ganit, Drexler Michael, Norman Doron, Peled Eli, Rozen Nimrod
AposTherapy Research Group, Herzliya, Israel.
Harefuah. 2011 Oct;150(10):769-73, 815.
The management of knee osteoarthritis (OA) focuses on reducing the levels of pain and disability. Recently, a novel biomechanical device and treatment methodology (AposTherapy) was shown to reduce the knee adduction moment while simultaneously challenging the neuromuscular control system through perturbation.
The purpose of the study was to investigate the changes in gait patterns and clinical measurements following treatment with a novel biomechanical device on patients with knee OA.
A total of 745 patients with bilateral knee OA were analyzed. Patients completed a gait test, Western Ontario and McMaster Osteoarthritis Index (WOMAC) questionnaire and SF-36 Health Survey at baseline and after 12 weeks. The biomechanical device was individually calibrated to each patient. Shifting the center of pressure, through changes in the location of the biomechanical elements causes realignment and reduction in the knee adduction moment. Furthermore the configuration of the biomechanical element allows training under controlled perturbation.
A significant decrease was found in WOMAC pain (28.6%) and WOMAC function (25.2%) following three months of therapy (p<0.001). A significant increase was found in the patients' physical quality of life (17.8%) and mental quality of life (11.0%) (p<0.001). Gait velocity, cadence step length, stance phase and single limb support phase improved significantly following three months of therapy (7.6%, 4%, 3.7% and 1.6%, respectively).
Our results suggest an overall improvement in the gait patterns, level of pain, function and quality of life of patients with knee OA following three months of AposTherapy.
膝关节骨关节炎(OA)的治疗重点在于减轻疼痛程度和残疾状况。最近,一种新型生物力学装置及治疗方法(Apos疗法)被证明可降低膝关节内收力矩,同时通过干扰对神经肌肉控制系统形成挑战。
本研究旨在调查使用新型生物力学装置治疗膝关节OA患者后其步态模式和临床测量指标的变化。
共分析了745例双侧膝关节OA患者。患者在基线期和12周后完成了步态测试、西安大略和麦克马斯特大学骨关节炎指数(WOMAC)问卷以及SF-36健康调查。生物力学装置针对每位患者进行了单独校准。通过改变生物力学元件的位置来移动压力中心,可实现重新排列并降低膝关节内收力矩。此外,生物力学元件的配置允许在可控干扰下进行训练。
治疗三个月后,WOMAC疼痛评分(28.6%)和WOMAC功能评分(25.2%)显著降低(p<0.001)。患者的身体生活质量(17.8%)和精神生活质量(11.0%)显著提高(p<0.001)。治疗三个月后,步态速度、步频、步长、站立期和单腿支撑期均有显著改善(分别提高7.6%、4%、3.7%和1.6%)。
我们的结果表明,膝关节OA患者接受三个月的Apos疗法后,其步态模式、疼痛程度、功能和生活质量总体上有所改善。